PEN: Rega marang dodolan Penumbra Inc
Penumbra, Inc. (PEN) maintains its reputation as a lifesaver in stroke treatment, bolstered by breakthrough developments in computer vision and VR rehabilitation. The revenue multiple trend visualizes the market valuation of these achievements, where the latest parameter stands at 8.10. Such a high business valuation is driven by the creation of a closed ecosystem of thrombectomy tools, making it virtually impossible for clinics to migrate to alternative systems.
Rincian analitis perusahaan Penumbra Corp (PEN)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Penumbra, Inc.|PEN - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Penumbra Medical|PEN - Utang perusahaan|Rasio utang marang kapitalisasi buku Penumbra Corp|PEN - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Penumbra|Likuiditas darurat penumbrainc.com
- indikator pendapatan resik lan kelipatan nilai:
PEN - Bathi resik perusahaan|Proyeksi bathi resik Penumbra, Inc.|PEN - Koefisien rega marang bathi|Pangali Forward P/E Penumbra Inc|PEN - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Penumbra Corp|PEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Penumbra|PEN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan penumbrainc.com|PEN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Penumbra, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:penumbrainc.com PEN
Geopolitical risks and electronics supply chain disruptions leave Penumbra, Inc. (PEN) revenue vulnerable to external shocks, necessitating a thorough analysis of market expectations. The capitalization-to-revenue ratio, represented by the price-to-sales multiple, determines the value of every dollar of sales, allowing investors to assess the asset's overbought status and identify a safe entry point amidst high volatility.
Karo sapa Penumbra, Inc. saingan
Kapitalisasi marang pendapatan dexcom.com DXCM|Multiplikator P/S NOVT (Novanta)|Haemonetics Corp (HAE) - Rega marang dodolan|Inspire Sleep - Multiplikator P/S|PRCT (Procept) - Rasio kapitalisasi marang pendapatan|CNMD: Multiplikator P/S|PLSE - Koefisien rega marang pendapatan|INMD (InMode) - Multiplikator P/S|Kapitalisasi marang pendapatan Picard Medical Corp (PMI)|Multiplikator P/S SRDX|Multiplikator P/S Eversense (SENS)|Rasio rega marang pendapatan NeuroPace, Inc. NPCE|Tactile Systems Technology, Inc. - Rasio rega marang pendapatan|SNWV: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan OM (Outset Medical Inc)|ELMD: Multiplikator P/S|Rega marang dodolan LENSAR Inc (LNSR)|Rasio rega marang pendapatan AVITA Medical, Inc.|PROF - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan BDMD (Baird Medical Investment)|Multiplikator P/S edap-tms.com (EDAP)|Multiplikator P/S APYX (Apyx Medical Corporation)|Koefisien rega marang pendapatan IceCure Medical Ltd. (ICCM)|LUNG - Rasio rega marang pendapatan|Rasio rega marang dodolan TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Sensus Healthcare Inc|ZYXI (Zynex Inc) - Multiplikator P/S|Rega marang dodolan electroCore Medical ECOR|Rasio rega marang pendapatan Vicarious Surgical Inc. (RBOT)|inspira-technologies.com - Rasio kapitalisasi marang pendapatan|SeaStar Medical - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan IRIX (IRIDEX Corp)|INBS - Rasio rega marang pendapatan|Rasio rega marang dodolan XAIR|PFSA: Multiplikator P/S|Rega marang dodolan STRATA Skin Sciences, Inc. (SSKN)|Rasio rega marang pendapatan GlucoTrack, Inc.|Rasio kapitalisasi marang pendapatan NAOV (nanovibronix.com)|Kapitalisasi marang pendapatan VERO (Venus Concept Corp)|Multiplikator P/S Nuwellis Corp (NUWE)|Rasio rega marang pendapatan Aethlon Medical AEMD|ASXC - Kapitalisasi marang pendapatan|Avinger - Multiplikator P/S|BSGM: Rasio rega marang pendapatan|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|Know Labs Corporation - Rasio kapitalisasi pasar marang pendapatan|NARI (Inari Medical, Inc.) - Multiplikator P/S|Multiplikator P/S nevro.com|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
